DXCM FY 2023 Earnings — DexCom, Inc. Revenue & Financial Results | Market Cap Arena

DXCMDexCom, Inc.

$27B

FY 2023 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$3.6B+24.5% YoY

Gross Profit

$2.3B63.2% margin

Operating Income

$598M16.5% margin

Net Income

$542M14.9% margin

EPS (Diluted)

$1.30

Cash Flow

Operating Cash Flow

$749M

Free Cash Flow

$512M

Stock-Based Comp.

$151M

Balance Sheet

Total Assets

$6.3B

Total Liabilities

$4.2B

Stockholders' Equity

$2.1B

Cash & Equivalents

$566M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$3.6B	$2.9B	+24.5%
Gross Profit	$2.3B	$1.9B	+21.5%
Operating Income	$598M	$391M	+52.8%
Net Income	$542M	$341M	+58.7%